eMedicine Specialties > Orthopedic Surgery > Neoplasms

Giant Cell Tumor of the Tendon Sheath: Workup

Author: James R Verheyden, MD, Consulting Surgeon, Department of Orthopedic Surgery, The Orthopedic and Neurosurgical Center of the Cascades
Coauthor(s): Timothy A Damron, MD, David G Murray Endowed Professor, Department of Orthopedic Surgery, Professor, Orthopedic Oncology and Adult Reconstruction, Vice Chair, Department of Orthopedics, State University of New York Upstate Medical University at Syracuse
Contributor Information and Disclosures

Updated: Jun 26, 2009

Workup

Imaging Studies


Radiograph demonstrates cortical erosion from the...

Radiograph demonstrates cortical erosion from the pressure effect of the adjacent mass on the radial aspect of the proximal phalanx.

Radiograph demonstrates cortical erosion from the...

Radiograph demonstrates cortical erosion from the pressure effect of the adjacent mass on the radial aspect of the proximal phalanx.



Radiograph demonstrates the bony erosion associat...

Radiograph demonstrates the bony erosion associated with some giant cell tumors of the tendon sheath and shows the unmineralized soft-tissue shadow of the mass.

Radiograph demonstrates the bony erosion associat...

Radiograph demonstrates the bony erosion associated with some giant cell tumors of the tendon sheath and shows the unmineralized soft-tissue shadow of the mass.



Radiograph demonstrates cortical erosion from the...

Radiograph demonstrates cortical erosion from the pressure effect of the overlying giant cell tumor of the tendon sheath. This apple-core effect is indicative of a primary soft-tissue mass that is causing external erosion, which should not be confused with a primary bone process such as periosteal chondroma.

Radiograph demonstrates cortical erosion from the...

Radiograph demonstrates cortical erosion from the pressure effect of the overlying giant cell tumor of the tendon sheath. This apple-core effect is indicative of a primary soft-tissue mass that is causing external erosion, which should not be confused with a primary bone process such as periosteal chondroma.



Typical T2-weighted MRI appearance of a giant cel...

Typical T2-weighted MRI appearance of a giant cell tumor of the tendon sheath. Most of the tumor has intermediate signal intensity, and portions of the tumor have low signal intensity; the latter finding likely reflects signal attenuation due to hemosiderin deposition.

Typical T2-weighted MRI appearance of a giant cel...

Typical T2-weighted MRI appearance of a giant cell tumor of the tendon sheath. Most of the tumor has intermediate signal intensity, and portions of the tumor have low signal intensity; the latter finding likely reflects signal attenuation due to hemosiderin deposition.



Typical T1-weighted MRI appearance of a giant cel...

Typical T1-weighted MRI appearance of a giant cell tumor of the tendon sheath. Portions of the tumor have decreased signal intensity.

Typical T1-weighted MRI appearance of a giant cel...

Typical T1-weighted MRI appearance of a giant cell tumor of the tendon sheath. Portions of the tumor have decreased signal intensity.



Typical T1-weighted MRI findings in a giant cell ...

Typical T1-weighted MRI findings in a giant cell tumor of the tendon sheath overlying the metacarpophalangeal joint. Note the low-signal-intensity areas.

Typical T1-weighted MRI findings in a giant cell ...

Typical T1-weighted MRI findings in a giant cell tumor of the tendon sheath overlying the metacarpophalangeal joint. Note the low-signal-intensity areas.


  • Plain radiography
    • Plain radiographs demonstrate a benign-appearing circumscribed soft-tissue shadow in 50% of cases. These radiographs also show cortical erosion of the bone due to a pressure effect of the adjacent mass on the cortex in 10-20% of cases (see Images 2-3).
    • True bone invasion is not typical and is suggestive of an aggressive neoplasm.
    • Cortical erosion from these tumors is more common in the feet than elsewhere because the strong ligaments in this region frequently prevent outward tumor growth.
    • Occasionally, intralesional soft-tissue calcification is seen with giant cell tumors of the tendon sheath. This intralesional calcification can be confused with synovial chondromatosis, periosteal chondroma, or calcific tendinitis.
    • On rare occasions when extensive cortical erosion is present, the lesion may have a radiographic appearance suggestive of a periosteal chondroma (see Images 4-7).
  • Magnetic resonance imaging (MRI)
    • Giant cell tumors of the tendon sheath frequently have a unique MRI appearance for an extra-articular soft-tissue mass.19,20 On both T1- and T2-weighted MRIs, at least some portions of the tumor have decreased signal intensity (see Images 8-11) similar to that seen with PVNS. However, this appearance is not entirely specific to giant cell tumors of the tendon sheath.
    • The degree to which these low–signal-intensity areas are present depends on the amount of hemosiderin, which varies. PVNS often has more low–signal-intensity areas on T2-weighted images, secondary to its higher hemosiderin content resulting from characteristic intralesional bleeding.
  • Sonography: For the value of sonograms, see studies by Bancroft et al 20 and Wang et al21

Histologic Findings


Gross pathologic findings

Giant cell tumors of the tendon sheath have a well-circumscribed multilobular appearance and often possess shallow grooves along their deep surfaces created by the underlying tendons. These tumors are usually small, with a diameter of 0.5-5 cm. Compared with other lesions, giant cell tumors in the hand digits are usually smaller and have a more regular appearance. Giant cell tumors in the feet and elsewhere are often larger and more irregular in appearance. On cut sections, these tumors have a mottled appearance, varying in color from grayish-brown to yellow-orange. The coloration depends on the amount of hemosiderin, collagen, and histiocytes in the sample. Tumors with more hemosiderin deposition due to bleeding have more of the yellow-orange or even reddish-brown color (see Images 12-14).

Intraoperative excision of the giant cell tumor o...

Intraoperative excision of the giant cell tumor of the tendon sheath shown in Image 9, which has the typical golden-yellow color secondary to hemosiderin deposition. The radial digital nerve is dissected free and slightly volar to the mass.

Intraoperative excision of the giant cell tumor o...

Intraoperative excision of the giant cell tumor of the tendon sheath shown in Image 9, which has the typical golden-yellow color secondary to hemosiderin deposition. The radial digital nerve is dissected free and slightly volar to the mass.



After excision, the bone is curetted, leaving the...

After excision, the bone is curetted, leaving the exposed radial aspect of the proximal phalanx, as shown here.

After excision, the bone is curetted, leaving the...

After excision, the bone is curetted, leaving the exposed radial aspect of the proximal phalanx, as shown here.



Giant cell tumor of the tendon sheath after margi...

Giant cell tumor of the tendon sheath after marginal excision.

Giant cell tumor of the tendon sheath after margi...

Giant cell tumor of the tendon sheath after marginal excision.


Microscopic findings

Most giant cell tumors of the tendon sheath are moderately cellular and composed of sheets of rounded or polygonal cells that blend with hypocellular collagenized zones. Variable numbers of giant cells are present (see Image 15). Hemosiderin-containing xanthoma cells are common and often localized at the periphery of the lesion (see Image 16).

Typical microscopic appearance of a giant cell tu...

Typical microscopic appearance of a giant cell tumor of the tendon sheath. Sheets of rounded or polygonal cells blend with hypocellular collagenized zones; variable numbers of giant cells are present.

Typical microscopic appearance of a giant cell tu...

Typical microscopic appearance of a giant cell tumor of the tendon sheath. Sheets of rounded or polygonal cells blend with hypocellular collagenized zones; variable numbers of giant cells are present.



High-power photomicrograph of giant cell tumor of...

High-power photomicrograph of giant cell tumor of the tendon sheath shows occasional numerous mononuclear cells, scattered giant cells, and hemosiderin-containing xanthoma cells.

High-power photomicrograph of giant cell tumor of...

High-power photomicrograph of giant cell tumor of the tendon sheath shows occasional numerous mononuclear cells, scattered giant cells, and hemosiderin-containing xanthoma cells.


In the localized form of the disease, a mature collagen capsule often surrounds the tumor. This capsule is continuous, with fibrous septa within the substance of the tumor that divide it into vague nodules. In the diffuse form, the tumor is not surrounded by this capsule and instead grows in expansive sheets.

Giant cells are also less common in the diffuse form. The histologic features of the localized and diffuse forms of giant cell tumor of the tendon sheath and the localized and diffuse forms of PVNS are essentially the same; therefore, these diseases form a histopathologic spectrum in which the tumors range from benign lesions to more locally aggressive lesions.

Cytopathologic findings

The predominant cell type is the mononuclear cell. These round-to-polygonal cells are found alone or in papillary clusters and have eccentrically located nuclei that lack pleomorphism. Varying amounts of refractile golden-brown crystals of hemosiderin are characteristically found within the histiocytes.22,23

More on Giant Cell Tumor of the Tendon Sheath

Overview: Giant Cell Tumor of the Tendon Sheath
Workup: Giant Cell Tumor of the Tendon Sheath
Treatment: Giant Cell Tumor of the Tendon Sheath
Follow-up: Giant Cell Tumor of the Tendon Sheath
Multimedia: Giant Cell Tumor of the Tendon Sheath
References
Further Reading

References

  1. Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. Sep-Oct 2008;28(5):1493-518. [Medline].

  2. Abdul-Karim FW, el-Naggar AK, Joyce MJ. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis. Hum Pathol. Jul 1992;23(7):729-35. [Medline].

  3. Mathews RE, Gould JS, Kashlan MB. Diffuse pigmented villonodular tenosynovitis of the ulnar bursa--a case report. J Hand Surg [Am]. Jan 1981;6(1):64-9. [Medline].

  4. Enzinger FM, Weiss SH. Benign tumors and tumorlike lesions of synovial tissue. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. St Louis, Mo: Mosby;1995:735-55.

  5. Abimelec P, Cambiaghi S, Thioly D. Subungual giant cell tumor of the tendon sheath. Cutis. Oct 1996;58(4):273-5. [Medline].

  6. Choudhury M, Jain R, Nangia A. Localized tenosynovial giant cell tumor of tendon sheath. A case report. Acta Cytol. May-Jun 2000;44(3):463-6. [Medline].

  7. Ciattaglia G, Filosa G, Bugatti L. Giant cell tumor of tendon sheath. J Am Acad Dermatol. Oct 1991;25(4):728-9. [Medline].

  8. LaRussa LR, Labs K, Schmidt RG. Giant cell tumor of tendon sheath. J Foot Ankle Surg. Nov-Dec 1995;34(6):541-6. [Medline].

  9. Schleicher SM. Giant cell tumor of tendon sheath. Cutis. Mar 1997;59(3):133-4. [Medline].

  10. Wu NL, Hsiao PF, Chen BF, et al. Malignant giant cell tumor of the tendon sheath. Int J Dermatol. Jan 2004;43(1):54-7. [Medline].

  11. Jones FE, Soule EH, Coventry MB. Fibrous xanthoma of synovium (giant-cell tumor of tendon sheath, pigmented nodular synovitis). A study of one hundred and eighteen cases. J Bone Joint Surg Am. Jan 1969;51(1):76-86. [Medline].

  12. Reginato A, Martinez V, Schumacher HR. Giant cell tumour associated with rheumatoid arthritis. Ann Rheum Dis. Jul 1974;33(4):333-41. [Medline].

  13. Hosaka M, Hatori M, Smith R, Kokubun S. Giant cell formation through fusion of cells derived from a human giant cell tumor of tendon sheath. J Orthop Sci. 2004;9(6):581-4. [Medline].

  14. Jaffe HL, Lichtenstein HL, Elsutro CJ. Pigmented villonodular synovitis, bursitis, and tenosynovitis. Arch Pathol. 1941;31:731-65.

  15. Darling JM, Goldring SR, Harada Y. Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts. Am J Pathol. Apr 1997;150(4):1383-93. [Medline].

  16. Wood GS, Beckstead JH, Medeiros LJ. The cells of giant cell tumor of tendon sheath resemble osteoclasts. Am J Surg Pathol. Jun 1988;12(6):444-52. [Medline].

  17. Vogrincic GS, O''Connell JX, Gilks CB. Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Hum Pathol. Jul 1997;28(7):815-9. [Medline].

  18. Stewart MJ. Benign giant-cell synovioma and its relation to "xanthoma". JBJS. 1948;30B:522-7.

  19. Jelinek JS, Kransdorf MJ, Shmookler BM. Giant cell tumor of the tendon sheath: MR findings in nine cases. AJR Am J Roentgenol. Apr 1994;162(4):919-22. [Medline].

  20. Bancroft LW, Peterson JJ, Kransdorf MJ. Imaging of soft tissue lesions of the foot and ankle. Radiol Clin North Am. Nov 2008;46(6):1093-103. [Medline].

  21. Wang Y, Tang J, Luo Y. The value of sonography in diagnosing giant cell tumors of the tendon sheath. J Ultrasound Med. Oct 2007;26(10):1333-40. [Medline].

  22. Agarwal PK, Gupta M, Srivastava A. Cytomorphology of giant cell tumor of tendon sheath. A report of two cases. Acta Cytol. Mar-Apr 1997;41(2):587-9. [Medline].

  23. Iyer VK, Kapila K, Verma K. Fine-needle aspiration cytology of giant cell tumor of tendon sheath. Diagn Cytopathol. Aug 2003;29(2):105-10. [Medline].

  24. Phalen GS, McCormack LJ, Gazale WJ. Giant-cell tumor of tendon sheath (benign synovioma) in the hand. Evaluation of 56 cases. Clin Orthop. 1959;15:140-51. [Medline].

  25. Moore JR, Weiland AJ, Curtis RM. Localized nodular tenosynovitis: experience with 115 cases. J Hand Surg [Am]. May 1984;9(3):412-7. [Medline].

  26. Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg [Am]. Nov 1999;24(6):1298-302. [Medline].

  27. Wright CJE. Benign giant-cell synovioma; an investigation of 85 cases. Br J Surg. Jan 1951;38(151):257-71. [Medline].

  28. Goda JS, Patil P, Krishnappan C, Elangovan D. Giant cell tumor of the tendon sheath treated by brachytherapy (surface mold) technique-A technical illustration. Brachytherapy. Oct 22 2008;[Medline].

  29. Rodrigues C, Desai S, Chinoy R. Giant cell tumor of the tendon sheath: a retrospective study of 28 cases. J Surg Oncol. Jun 1998;68(2):100-3. [Medline].

  30. Darwish FM, Haddad WH. Giant cell tumour of tendon sheath: experience with 52 cases. Singapore Med J. Nov 2008;49(11):879-82. [Medline].

  31. Messoudi A, Fnini S, Labsaili N, Ghrib S, Rafai M, Largab A. [Giant cell tumors of the tendon sheath of the hand: 32 cases]. Chir Main. Jun 2007;26(3):165-9. [Medline].

  32. Gholve PA, Hosalkar HS, Kreiger PA, Dormans JP. Giant cell tumor of tendon sheath: largest single series in children. J Pediatr Orthop. Jan-Feb 2007;27(1):67-74. [Medline].

Further Reading

Related eMedicine topics

Giant Cell Tumor
 (Orthopedic Surgery)

Giant Cell Tumor (Radiology)

Keywords

giant cell tumor, localized nodular tenosynovitis, fibrous xanthoma, xanthoma of the synovium, xanthoma of the tendon sheath, xanthogranuloma, xanthosarcoma, fibroma of tendon, myeloid endothelioma, endothelioma, villous arthritis, fibrohemosideric sarcoma, giant cell fibrohemangioma, benign synovioma, sclerosing hemangioma, pigmented villonodular synovitis

Contributor Information and Disclosures

Author

James R Verheyden, MD, Consulting Surgeon, Department of Orthopedic Surgery, The Orthopedic and Neurosurgical Center of the Cascades
James R Verheyden, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Medical Association, and American Society for Surgery of the Hand
Disclosure: Nothing to disclose.

Coauthor(s)

Timothy A Damron, MD, David G Murray Endowed Professor, Department of Orthopedic Surgery, Professor, Orthopedic Oncology and Adult Reconstruction, Vice Chair, Department of Orthopedics, State University of New York Upstate Medical University at Syracuse
Timothy A Damron, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Medical Association, Children's Oncology Group, Connective Tissue Oncology Society, Musculoskeletal Tumor Society, Orthopaedic Research Society, and Society for Experimental Biology and Medicine
Disclosure: Lippincott, Williams, and Wilkins Royalty Editing/writing textbook; Genentech Grant/research funds Clinical research; Orthovita Grant/research funds Clinical research; National Institutes of Health Grant/research funds Clinical research

Medical Editor

Timothy A Damron, MD, David G Murray Endowed Professor, Department of Orthopedic Surgery, Professor, Orthopedic Oncology and Adult Reconstruction, Vice Chair, Department of Orthopedics, State University of New York Upstate Medical University at Syracuse
Timothy A Damron, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Medical Association, Children's Oncology Group, Connective Tissue Oncology Society, Musculoskeletal Tumor Society, Orthopaedic Research Society, and Society for Experimental Biology and Medicine
Disclosure: Lippincott, Williams, and Wilkins Royalty Editing/writing textbook; Genentech Grant/research funds Clinical research; Orthovita Grant/research funds Clinical research; National Institutes of Health Grant/research funds Clinical research

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Sean P Scully, MD, PhD, Professor, Department of Orthopedics, University of Miami
Sean P Scully, MD, PhD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, International Society on Thrombosis and Haemostasis, and Society of Surgical Oncology
Disclosure: Nothing to disclose.

CME Editor

Dinesh Patel, MD, FACS, Associate Clinical Professor of Orthopedic Surgery, Harvard Medical School; Chief of Arthroscopic Surgery, Department of Orthopedic Surgery, Massachusetts General Hospital
Dinesh Patel, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Association of Physicians of Indian Origin, American College of International Physicians, and American College of Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Harris Gellman, MD, Consulting Surgeon, Broward Hand Center; Voluntary Clinical Professor of Orthopedic Surgery and Plastic Surgery, Departments of Orthopedic Surgery and Surgery, University of Miami School of Medicine
Harris Gellman, MD is a member of the following medical societies: American Academy of Medical Acupuncture, American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American Society for Surgery of the Hand, and Arkansas Medical Society
Disclosure: Nothing to disclose.

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.